Fisher & Paykel Healthcare Corporation Limited (ASX: FPH)

Market Cap	19.59B
Revenue (ttm)	1.60B
Net Income (ttm)	121.67M
Shares Out	n/a
EPS (ttm)	0.21
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Jun 26, 2024

Volume	435,620
Open	33.85
Previous Close	33.56
Day's Range	33.32 - 34.16
52-Week Range	20.17 - 35.76
Beta	0.42
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 21, 2024

About FPH

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1934
• Employees: 7,031
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: FPH

Financial Performance

In 2023, FPH's revenue was 1.74 billion, an increase of 10.23% compared to the previous year's 1.58 billion. Earnings were 132.60 million, a decrease of -47.02%.

Financial numbers in NZD